Release Date: February 05, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Have you worked through the higher cost NHPs, and what are the current ordering patterns from customers? A: (CEO) We have worked through all the higher cost NHPs. Ordering patterns have stabilized, and we have more solid commitments for this year compared to last year. We anticipate more consistent revenue streams with reduced volatility.
Q: How could the potential halt of NHP exports from Cambodia impact the global supply and demand dynamics? A: (CEO) Cambodia is a significant part of the global supply base. If exports stop, it will pressure other supply bases. We are prepared for either scenario and have diversified our supply sources to mitigate risks.
Q: Can you provide guidance on adjusted EBITDA expectations for the fiscal year? A: (CEO) While not providing specific guidance, we expect year-over-year sales growth and improved margins as we progress through the year. We are ahead of our original covenant expectations and anticipate positive EBITDA growth.
Q: Did any NHP sales slip from Q1 into Q2, and how does this affect revenue? A: (CEO) Yes, some sales slipped into Q2, which can shift revenue by a few million dollars. However, this is a short-term shift, and we expect less volatility compared to last year.
Q: What is the impact of cancellations on your book-to-bill ratio, and what caused the recent increase in cancellations? A: (CEO) We had a significant $4 million project cancellation, which impacted the book-to-bill ratio. This was an anomaly, and we are seeing positive trends in new awards, particularly in discovery services.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。